Prof. Guiqiang Wang
Dear Colleagues,

On behalf of the Organizing Committee and Scientific Committee, it is our great pleasure to welcome you to join the APASL STC 2018, which will be held on 6 - 8 December 2018 in Beijing, China.

The recent breakthrough in liver immunology has been translating to the medications which provided the hope to cure viral hepatitis B and C. Unfortunately, the nature and range of initiating agents of autoimmune liver diseases (AILD) are still remain unknown. Also, AILD always have additional forms of autoimmunity and comprehensive approach to diagnose and treat multiple autoimmune conditions is needed to keep symptoms under control.

In this conference, we will develop the program covering the basic immunology, application of liver immunology for diagnosis, and provide a solid foundation for understanding immune-mediated liver disease. Renowned experts will be invited to share their insights for the pathogenesis and clinical management of autoimmune liver diseases including Primary biliary cholangitis (PBC), autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC), overlap syndrome as well as IgG4.

If you are the one working in the field wanna translate science into new therapies and care pathways, please come and join us. You are more than welcome to share your thoughts and research findings by submitting abstract to the conference.

Apart from the above there is much more waiting for you to discover in Beijing, the ancient city and capital of China.

Prof. Guiqiang Wang
Congress Chairman